EP 0921809 A1 19990616 - USE OF PROLACTIN AS A TGF-BETA ANTAGONIST
Title (en)
USE OF PROLACTIN AS A TGF-BETA ANTAGONIST
Title (de)
VERWENDUNG VON PROLACTIN ALS TGF-BETA ANTAGONIST
Title (fr)
UTILISATION DE LA PROLACTINE COMME UN ANTAGONISTE DE TGF-BETA
Publication
Application
Priority
- US 9707310 W 19970430
- US 1649296 P 19960430
Abstract (en)
[origin: WO9740848A1] This invention is based upon the discovery that prolactin has been found to counter the effect that TGF- beta has on cells. An object of the present invention is to claim a method for treating a patient that may be suffering from a disease or disorder which is associated with the presence of TGF- beta , by administering an effective amount of a pharmaceutically acceptable composition containing prolactin.
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); A61K 38/22 (2006.01); A61P 1/00 (2006.01); A61P 1/16 (2006.01); A61P 11/00 (2006.01); A61P 37/00 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A61K 38/225 (2013.01); A61P 1/00 (2017.12); A61P 1/16 (2017.12); A61P 11/00 (2017.12); A61P 37/00 (2017.12); A61P 43/00 (2017.12)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9740848 A1 19971106; AU 2749697 A 19971119; CA 2232682 A1 19971106; EP 0921809 A1 19990616; EP 0921809 A4 20011024; JP 2000510112 A 20000808
DOCDB simple family (application)
US 9707310 W 19970430; AU 2749697 A 19970430; CA 2232682 A 19970430; EP 97921467 A 19970430; JP 53920697 A 19970430